Octreotide Use in a Patient with MEN-1 Syndrome and Multifocal Pancreatic Neuroendocrine Tumors: A Case Report and Review of the Literature

Octreotide Use in a Patient with MEN-1 Syndrome and Multifocal Pancreatic Neuroendocrine Tumors: A Case Report and Review of the Literature

We report a patient with multiple endocrine neoplasia type 1 with pancreatic polypeptide (PP) secreting subcentimeter pancreatic neuroendocrine tumors (pNETs) treated with octreotide and review the current literature that pertains to the management of these patients. Clinical data, laboratory result...

Full description

Bibliographic Details
Main Authors:	Matthew H. Kemm, Cory D. Manly, Thanh D. Hoang, Vinh Q. Mai, Mohamed K. M. Shakir
Format:	Article
Language:	English
Published:	Hindawi Limited 2019-01-01
Series:	Case Reports in Gastrointestinal Medicine
Online Access:	http://dx.doi.org/10.1155/2019/9462942

Similar Items

Long lasting octreotide LAR therapy in non functioning pancreatic neuroendocrine carcinoma
by: Ivan Lolli, et al.
Published: (2015-10-01)

Octreotide in the treatment of neuroendocrine carcinomas: Is the success achieved?
by: L. Yu. Morgunov
Published: (2015-06-01)

Development of a method for preparing octreotide derivative for diagnosis of neuroendocrine tumors
by: M. S. Larkina, et al.
Published: (2019-10-01)

Octreotide Does Not Inhibit Proliferation in Five Neuroendocrine Tumor Cell Lines
by: Samantha Exner, et al.
Published: (2018-04-01)

Diagnostic accuracy of technetium-99m-octreotide in imaging neuroendocrine tumors, Oman hospital experience with literature review
by: Naima Al Bulushi, et al.
Published: (2019-01-01)

Octreotide long-acting repeatable in the treatment of neuroendocrine tumors: patient selection and perspectives
by: Yau H, et al.
Published: (2017-12-01)

The effect of using long-acting octreotide as adjuvant therapy for patients with grade 2 pancreatic neuroendocrine tumors after radical resection
by: Suizhi Gao, MM, et al.
Published: (2020-12-01)

The Clinico-epidemiologic Characteristics of Iraqi Patients with Neuroendocrine Tumors and Their Response to Long Acting Octreotide
by: Marwah K. Abdulfattah, et al.
Published: (2016-01-01)

First Case of Regression of Carcinoid Heart Disease on Serial Transthoracic Echocardiograms following Octreotide Monotherapy in a Patient with Metastatic Pancreatic Neuroendocrine Tumor
by: Ermin Nath, et al.
Published: (2020-12-01)

Refractory Thrombocytopenia Responds to Octreotide Treatment in a Case of Evans Syndrome with Gastric Neuroendocrine Tumor
by: Kocfa Chung-Delgado, et al.
Published: (2013-01-01)

Refractory Thrombocytopenia Responds to Octreotide Treatment in a Case of Evans Syndrome with Gastric Neuroendocrine Tumor
by: Chung Delgado, Kocfa, et al.
Published: (2014)

Metastatic Moderately Differentiated Neuroendocrine Carcinoma Of The Larynx Mimicking Medullary Thyroid Cancer
by: Terry Shin, MD, et al.
Published: (2017-01-01)

The neuroendocrine markers assay and the glycemia profile in patients with neuroendocrine tumors under octreotide therapy: a 2 years study / Determinarea markerilor neuroendocrini şi a profilului glicemic la pacienţii cu tumori neuroendocrine în tratament cu octreotid
by: Poiană Cătălina, et al.
Published: (2014-09-01)

The somatostatin analogue octreotide inhibits growth of small intestine neuroendocrine tumour cells.
by: Su-Chen Li, et al.
Published: (2012-01-01)

Expression of transcription factors in MEN1-associated pancreatic neuroendocrine tumors
by: Yasutaka Takeda, et al.
Published: (2017-09-01)

Treatment with Lanreotide Depot Following Octreotide Long-Acting Release Among Patients with Gastroenteropancreatic Neuroendocrine Tumors
by: Muhammad Wasif Saif, et al.
Published: (2018-10-01)

Ascite pancreática: tratamento com octreotide: relato de caso = Pancreatic ascites: treatment with octreotide: case report
by: Diogo, Luciano Passamani, et al.
Published: (2005-01-01)

Pancreatic neuroendocrine tumors
by: Modesto J. Varas-Lorenzo, et al.

Long lasting octreotide LAR therapy in large cell neuroendocrine carcinoma (LCNEC) of the lung
by: Alfredo Butera
Published: (2015-10-01)

Hypovascular pancreatic neuroendocrine tumor with hepatic metastases: A case report and literature review
by: Ngo-Van Doan, MD, et al.
Published: (2021-06-01)

Lanreotide for the treatment of patients with disseminated high-grade neuroendocrine tumors: the experience of application in case of unsatisfactory tolerability of octreotide
by: G S Emelyanova, et al.
Published: (2016-03-01)

Long-Term Efficacy of S-1 Chemotherapy plus Administration of Octreotide for a Patient with Metastatic Neuroendocrine Tumor (Gastrinoma)
by: Sakura Hiraide, et al.
Published: (2017-05-01)

Somatostatin-receptor avidity of pancreatic neuroendocrine tumor thrombus in porto-caval venous systems on 99mTc-Octreotide and posttherapeutic 177Lu-DOTA-TATE scans
by: Mahasti Amoui, et al.
Published: (2021-01-01)

Pancreatic Neuroendocrine Tumors Presenting with Hypercalcitonemia
by: Alexandra Chrisoulidou, MD, PhD, et al.
Published: (2015-01-01)

Differentiation between gastrointestinal neuroendocrine tumors and pancreatic neuroendocrine tumors
by: LI Xiaoqing
Published: (2013-07-01)

Somatostatin versus octreotide in the treatment of patients with gastrointestinal and pancreatic fistulas
by: Emanuel Leandros, et al.
Published: (2004-01-01)

Diagnosis of Pancreatic Neuroendocrine Tumors
by: Dong Wook Lee, et al.
Published: (2017-11-01)

Imaging in Pancreatic Neuroendocrine Tumors
by: Savinay Kapur, et al.
Published: (2020-01-01)

Pancreatic paraganglioma mimicking pancreatic neuroendocrine tumor
by: Arezou Abbasi, et al.
Published: (2020-12-01)

Pancreatic Neuroendocrine Tumor Presenting as Acute Pancreatitis
by: Minjeong Kim, et al.
Published: (2018-02-01)

Effect of octreotide on enteric motor neurons in experimental acute necrotizing pancreatitis.
by: Hui Zhou, et al.
Published: (2012-01-01)

Agenesis of dorsal pancreas associated with pancreatic neuroendocrine tumor: a case report and review of the literature
by: A. Erotokritou, et al.
Published: (2018-06-01)

Randomized controlled study of the effect of octreotide on pancreatic exocrine secretion and pancreatic fistula after pancreatoduodenectomy
by: Dong Do You, et al.
Published: (2019-02-01)

Pancreatic Hemangioma Suspected of Neuroendocrine Tumor
by: Mo Ah Jeong, et al.
Published: (2020-07-01)

Molecular Pathogenesis of Pancreatic Neuroendocrine Tumors
by: Robert Grützmann, et al.
Published: (2010-11-01)

Treatment Options for Pancreatic Neuroendocrine Tumors
by: Amit Akirov, et al.
Published: (2019-06-01)

Pancreatic neuroendocrine tumors: prognostic factors
by: Javier A. Cienfuegos, et al.

Octreotide Conjugates for Tumor Targeting and Imaging
by: Eduard Figueras, et al.
Published: (2019-05-01)

Evolving Diagnostic and Treatment Strategies for Pancreatic Neuroendocrine Tumors
by: Picus Joel, et al.
Published: (2011-06-01)

Effects of octreotide combined with gabexate on related cytokines in patients with severe acute pancreatitis
by: Xiao-Ming Huang, et al.
Published: (2018-08-01)